FDA launches review of COX-Two inhibitors, warns caution on all ...
116025
WASHINGTON The Food and Drug Administration has ordered a sweeping review of studies involving prescription painkillers like Celebrex and Bextra.
189407
U.S. regulators have "serious concerns"  about painkilling drugs in the class known as COX-2 inhibitors  and are due to issue a new ruling on them within days, the  Financial Times reported on its Web site on Sunday.
205695
The US Food and Drug Administration on Friday asked an outside group to review the way it monitors safety risks associated with medicines already on the market, such as Merck &amp; Co.
905
Two leading heart experts called for  urgent investigations on Wednesday into whether all painkilling  drugs known as COX-2 inhibitors may raise the risk of heart  attack in some people.
211731
The Food and Drug Administration on Thursday ordered a review of all prevention studies involving drugs such as Celebrex and Bextra, which have been associated with increased risk of heart problems. The agency also urged the public to limit use of over-the-counter pain medications.
68020
Federal health officials  yesterday proposed sterner warning labels for acetaminophen, aspirin and ibuprofen, again cautioning millions of Americans who take the nonprescription pain relievers regularly of potentially serious side effects.
15642
NEW YORK, December 21  - The US Food and Drug Administration (FDA) warned today against the long-term usage of another arthritis drug, naproxen, after studies revealed increased risks of cardiovascular events.
513761
The U.S. Food and Drug Administration on Friday asked an outside group to review the way it monitors safety risks associated with medicines already on the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
4299
BEIJING, Dec. 22 -- The Chinese State Food and Drug Administration (SFDA) advised patients to be cautious when using the drug Celebrex for treating osteoarthritis.
604319
The Food and Drug Administration issued a warning to users of the over-the-counter pain reliever naproxen Monday after federal researchers found an increased number of heart attacks and strokes among users.
153246
More evidence of how painkillers  called COX-2 inhibitors can raise the risk of heart disease was  published Monday, showing Pfizer Inc.'s Bextra can triple the  risk of heart attack and stroke in certain patients.
178529
Benefits must exceed risks if COX-2 inhibitors are prescribed; patients need to stick to labeled NSAID dosages, limit use to 10 days.
34608
GAITHERSBURG, Md.  - U.S. scientific advisers  began hearing evidence on Wednesday about the benefits and  risks of pain killers taken by millions of Americans as  regulators weigh moves following Merck & Co. Inc.'s recall of  its arthritis pill Vioxx.
440274
Congress has been investigating the FDA&#39;s decisions in both the Vioxx and antidepressant cases. The probes have focused on agency reviewers who warned about potential problems but claimed their research was ignored or suppressed by other officials.
652888
The European Commission has ordered a full-scale probe into the safety of five remaining Cox-2 arthritis drugs, following last month's worldwide withdrawal of Merck & Co Inc.'s Vioxx.
433569
The European Commission has ordered a full-scale probe into the safety of five remaining Cox-2 arthritis drugs, following last month&#39;s
664479
Doctors treating people for chronic pain should avoid using all medications -- at least at first -- the American Heart Association advised yesterday in guidelines designed to have a significant impact on the use of medications known as nonsteroidal anti-inflammatory drugs, or NSAIDs.